Clinical Trial Update: A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating olanzapine for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: Korean South West Oncology Group | Conditions: Cancer | Phase 2 | Status: UNKNOWN